Engineering the future
of human lifespan

Next-generation genome editing to reverse aging and extend healthy life.

Learn our mission
Skybeetle Bio, LLC

Genome editing for radical life extension

We are a biotechnology company developing precision genome-editing therapies that target the fundamental drivers of aging. By combining state-of-the-art CRISPR-based tools with advanced cellular reprogramming, we aim to preserve youthful cellular function and dramatically extend human healthspan.

Our work draws on decades of pioneering genetic research and seeks to translate the most promising scientific insights into practical, safe solutions for age-related disease — by addressing aging itself.

CRISPR gene editing lab
Roman Oliynyk

Meet the Founder

Roman Oliynyk began his career in semiconductor physics and theoretical physics before diversifying into business enterprises. Fascinated by the transformative promise of genomic knowledge opened by the CRISPR revolution, he returned to science and spent nearly five years as a postdoctoral fellow in the Church Lab at Harvard Medical School, Department of Genetics.

Driven by the understanding that aging while inevitable may be modifiable - a solvable engineering problem, Roman founded Skybeetle Bio to translate the most promising academic discoveries into therapies that in conjunction with IVF selection can meaningfully extend human healthy lifespan. His vision is simple yet profound: give every person more years of vibrant, disease-free life.

We are currently in research and development mode.